ENTRY       D01112                      Drug
NAME        Adapalene (JAN/USP/INN);
            Differin (TN)
PRODUCT     DIFFERIN (GALDERMA LABORATORIES)
            DIFFERIN (Galderma Laboratories)
            DIFFERIN (Galderma Laboratories)
  GENERIC   ADAPALENE (Actavis Pharma)
            ADAPALENE (Alembic Pharmaceuticals)
            ADAPALENE (Bryant Ranch Prepack)
            ADAPALENE (CALL INC. (dba Rochester Pharmaceuticals))
            ADAPALENE (E. Fougera & Co. a division of Fougera Pharmaceuticals)
            ADAPALENE (Glenmark Pharmaceuticals)
            ADAPALENE (Mayne Pharma)
            ADAPALENE (Padagis Israel Pharmaceuticals)
            ADAPALENE (Prasco Laboratories)
            ADAPALENE (Taro Pharmaceuticals U.S.A.)
            ADAPALENE GEL USP, 0.3% (Encube Ethicals Private Limited)
            ADAPALENE TOPICAL SOLUTION (Allegis Holdings LLC)
            ADAPALENE TOPICAL SOLUTION (CALL INC (d.b.a Rochester Pharmaceuticals))
FORMULA     C28H28O3
EXACT_MASS  412.2038
MOL_WEIGHT  412.5201
CLASS       Vitamin and mineral
             DG01604  Retinol derivative
REMARK      Therapeutic category: 2699
            ATC code: D10AD03
            Product: D01112<JP/US>
            Product (mixture): D10792<JP/US>
EFFICACY    Anti-acne, Retinoic acid receptor (RAR) agonist
  DISEASE   Acne vulgaris [DS:H01445]
TARGET      NR1B3 (RARG) [HSA:5916] [KO:K08529]
            NR1B2 (RARB) [HSA:5915] [KO:K08528]
            NR2B3 (RXRG) [HSA:6258] [KO:K08526]
            NR2B2 (RXRB) [HSA:6257] [KO:K08525]
  PATHWAY   hsa04659(6257+6258)  Th17 cell differentiation
STR_MAP     map07223  Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AD Retinoids for topical use in acne
                 D10AD03 Adapalene
                  D01112  Adapalene (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Acne and Rosacea Agents
               Retinoids
                Adapalene
                 D01112  Adapalene (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               269  Miscellaneous
                2699  Others
                 D01112  Adapalene (JAN/USP/INN)
            Drug groups [BR:br08330]
             Vitamin and mineral
              DG01604  Retinol derivative
               D01112  Adapalene
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Thyroid hormone like receptors
               Retinoic acid receptor (RAR)
                NR1B2 (RARB)
                 D01112  Adapalene (JAN/USP/INN) &lt;JP/US&gt;
                NR1B3 (RARG)
                 D01112  Adapalene (JAN/USP/INN) &lt;JP/US&gt;
              Hepatocyte nuclear factor 4 like receptors
               Retinoid X receptor (RXR)
                NR2B2 (RXRB)
                 D01112  Adapalene (JAN/USP/INN) &lt;JP/US&gt;
                NR2B3 (RXRG)
                 D01112  Adapalene (JAN/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01112  Ibuprofen piconol
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01112
            Rx-to-OTC switch list in the USA [br08315.html]
             D01112
DBLINKS     CAS: 106685-40-9
            PubChem: 7848175
            ChEBI: 31174
            LigandBox: D01112
            NIKKAJI: J399.566F
ATOM        31
            1   C1z C    17.7219  -19.1703
            2   C1x C    16.9759  -20.6495
            3   C1y C    16.9759  -21.9529
            4   C1y C    16.5531  -21.1864
            5   C1y C    18.8839  -21.1864
            6   C1x C    15.2964  -22.4094
            7   C1x C    18.1087  -23.0011
            8   C1x C    16.5531  -19.8380
            9   C1x C    17.7237  -21.8606
            10  C1x C    18.8874  -19.8380
            11  C8x C    20.0526  -13.7790
            12  C8y C    20.0526  -15.1274
            13  C8x C    21.2231  -15.8016
            14  C8x C    21.2231  -13.1048
            15  C8y C    22.3869  -13.7790
            16  C8y C    22.3811  -15.1274
            17  C8x C    23.5460  -15.8065
            18  C8x C    24.7166  -15.1374
            19  C8y C    24.7223  -13.7890
            20  C8x C    23.5574  -13.1099
            21  C8y C    18.8851  -15.8022
            22  C8x C    17.7197  -15.1251
            23  C8x C    16.5524  -15.8000
            24  C8y C    16.5531  -17.1484
            25  C8y C    17.7212  -17.8219
            26  C8x C    18.8885  -17.1472
            27  C6a C    25.8929  -13.1198
            28  O6a O    27.0577  -13.7989
            29  O6a O    25.8988  -11.7714
            30  O2a O    15.3856  -17.8232
            31  C1a C    15.3864  -19.1716
BOND        36
            1    14  11 1
            2     1   2 1
            3     2   3 1
            4     8   4 1
            5     4   9 1
            6     9   5 1
            7    15  16 1
            8    16  17 1
            9    17  18 2
            10   18  19 1
            11   19  20 2
            12   20  15 1
            13    5  10 1
            14   12  21 1
            15   10   1 1
            16    1   8 1
            17    3   6 1
            18    3   7 1
            19    4   6 1
            20   21  22 2
            21   22  23 1
            22   23  24 2
            23   24  25 1
            24   25  26 2
            25   26  21 1
            26    5   7 1
            27   19  27 1
            28   11  12 2
            29   27  28 2
            30   12  13 1
            31   27  29 1
            32   13  16 2
            33   24  30 1
            34   15  14 2
            35   30  31 1
            36   25   1 1
///
